Leadership transitions can slow decisions at the top, but they do not pause market expansion. Reusable MedTech sales enablement playbooks help business units maintain consistent messaging, market-entry materials and customer conversations while the organisation changes.
The growth plan did not wait for a new CEO to be named
A MedTech company loses its CEO without a succession plan in place. An interim leader steps up and the search for a permanent replacement begins.
During those same few months, the company signs a new joint venture in one region, deepens its stake in another and commits to new manufacturing investments in two more.
The growth plan clearly did not get the memo that leadership was supposed to be in transition.
That is not necessarily a contradiction. It is often the normal state of a large, healthy business. But beneath the announcements, it creates a less visible commercial challenge.
Decentralised business units create a sales consistency gap
Years earlier, the company reorganised into several independently managed business units. Each unit received end-to-end responsibility for its own commercial results.
The logic is sound: teams move closer to customers, decisions become faster and accountability becomes clearer.
But decentralisation also means there may no longer be one central engine responsible for keeping every business unit’s value story, sales materials and customer conversations aligned.
This becomes especially visible when multiple business units enter new markets, establish partnerships or onboard new commercial teams at the same time.
Why leadership change increases sales enablement risk
When the organisation’s leadership is in transition, each business unit understandably concentrates on its own priorities, markets and financial targets.
Nobody deliberately neglects shared sales tools or consistent market-entry materials. It is simply not always clear who owns them.
That lack of ownership appears at precisely the moment when consistency matters most. New market teams need to understand how to introduce the company, explain its value and respond to customer questions without creating a new version of the story every time.
Without reusable sales enablement materials, each business unit, region or partner may begin adapting the message independently. Over time, those small differences can develop into different commercial narratives.
Sales enablement is commercial infrastructure
In this context, medtech sales enablement means creating reusable messaging, content and commercial tools that help teams explain value consistently across markets, partnerships and customer groups.
The businesses that manage leadership transitions well do not pause their commercial preparation until a permanent CEO has been appointed.
They treat sales enablement as infrastructure.
That infrastructure can include:
- A shared value story with clear proof points
- Market-entry playbooks for new regions and teams
- Conversation starters adapted to different customer roles
- Battlecards covering competitors, objections and buying criteria
- Local sales materials that remain connected to one central narrative
Together, these elements form a sales enablement architecture that gives commercial teams the right content and guidance for different stages of the customer conversation.
These tools are built around the needs of each business unit, but designed so that any new market team can use them immediately.
The objective is not to remove local flexibility. It is to prevent every team from having to invent the commercial argument again from a blank page.
The question every business unit should ask
The most useful question is not: When will things settle down at the top?
It is: Which of our business units is entering a new market without a consistent and reusable way to tell its story?
Leadership clarity may take time. Market opportunities rarely wait for it.
A clear sales enablement foundation allows commercial teams to keep moving while the wider organisation determines what comes next.
How Living Stone supports medtech sales enablement
This is part of our Sales Enablement work at Living Stone.
We build reusable playbooks, conversation starters, messaging frameworks and battlecards that commercial teams can use from the moment they enter a new market.
The result is not simply more sales content. It is a more consistent way for business units, regional teams and commercial partners to explain complex value, independent of whatever is happening several floors up.
If this challenge sounds familiar, discover how we approach Sales Enablement and start a conversation with our team.
Frequently asked questions
Why is sales enablement important during a leadership transition?
Sales enablement gives commercial teams an agreed story, relevant content and practical tools they can continue using while leadership roles and organisational priorities are changing. This helps reduce inconsistencies across markets and business units.
What should a medtech sales enablement playbook contain?
A MedTech sales enablement playbook can include the company’s value proposition, customer-specific messages, clinical or commercial proof points, objection handling, competitor guidance, conversation starters and recommended follow-up materials.
How does sales enablement support medtech market expansion?
Sales enablement helps new market teams explain complex products and value propositions without rebuilding the entire commercial story locally. Teams can adapt the message to their market while remaining consistent with the wider organisation.
